Open access
Aug 2026
Unlocking the value of RSV vaccination in Japan: a return on investment analysis using an integrated actuarial-macroeconomic model
Overall, adjuvanted RSVPreF3 vaccination among older adults in Japan represents good value for money from a societal perspective, where vaccine acquisition and administration costs are expected to be outweighed by substantial health, productivity, and broader economic benefits.
Eleftherios Zarkadoulas, A. Akimoto, Deven Chauhan et al.
· Frontiers in Public Health · 0 citations